MedTrace Logo

Afamin in Gestational Diabetes Mellitus

NCT04054843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-12-16

No results posted yet for this study

Summary

This study includes pregnancies in 11 to 14 th gestational weeks. Investigators will sample maternal plasma in the first trimester and analyze maternal plasma afamin values. All these women will then be screened by two step OGTT. Investigators will compare afamin levels in GDM and control groups.

Conditions

  • Gestational Diabetes Mellitus in Pregnancy

Interventions

DIAGNOSTIC_TEST

Afamin

Plasma maternal afamin levels

Sponsors & Collaborators

  • Ankara University

    collaborator OTHER

  • Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-03-01
Completion
2020-03-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04054843 on ClinicalTrials.gov